Duality Biologics
DualityBio is a clinical stage company focusing on the discovery and development of the next generation ADC therapeutics to treat patients in cancer and autoimmune diseases.
Employees
Enterprise value
$360—540m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor | €0.0 | round | |
* | N/A | $213m | IPO |
| Total Funding | 000k | ||
WuXi Biologics(exited)
Lilly Asia Ventures(exited)
YUNION Healthcare Fund(exited)
Huagai Capital(exited)
NRL Capital(exited)
Green Pine Capital(exited)
Oriza Holdings(exited)
King Star Capital(exited)
6 Dimensions Capital(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads